Trial Profile
A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis Dependent
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Daprodustat (Primary) ; Acetylcholine; Darbepoetin alfa; Sodium nitroprusside; Tilarginine
- Indications Anaemia
- Focus Pharmacodynamics
- Acronyms FBF-CKD
- Sponsors GlaxoSmithKline
- 02 Dec 2020 Status changed from recruiting to discontinued.
- 08 Jun 2020 Status changed from suspended to recruiting.
- 30 Apr 2020 Status changed from recruiting to suspended.